COVID-19 and CVD: Managing High-Risk Patients
Update: 2025-07-23
Description
COVID-19 and CVD: Managing High-Risk Patients
In this interview Dr Anita Sharma speaks with Dr Alicia Chan, Director and Cardiologist, Western Heart Care, Clinical and Academic Cardiologist, South Australia.
While many Australians now view COVID-19 as a mild illness, the reality is far more complex – especially for high-risk individuals.
In this compelling discussion we cover the ongoing consequences of COVID-19, particularly for those with cardiovascular disease, diabetes, and obesity. We explore the critical role of antiviral therapy, navigating drug interactions, and practical steps for protecting vulnerable patients.
With expert insights and real-world scenarios, this conversation is a must-listen for GPs striving to stay ahead of the evolving challenges of COVID-19.
This interview is for healthcare professionals only.
This interview is produced by DrivetimeRadio with the support of The Baker Heart and Diabetes Institute in collaboration with Pfizer Australia Pty Limited. Sydney, Australia. PP-C1D-AUS-0522, 06/25. Please go to our website to access CPD options, supporting references, resources, and the product PI: www.drivetimeradio.com.au/programs/gp/
In this interview Dr Anita Sharma speaks with Dr Alicia Chan, Director and Cardiologist, Western Heart Care, Clinical and Academic Cardiologist, South Australia.
While many Australians now view COVID-19 as a mild illness, the reality is far more complex – especially for high-risk individuals.
In this compelling discussion we cover the ongoing consequences of COVID-19, particularly for those with cardiovascular disease, diabetes, and obesity. We explore the critical role of antiviral therapy, navigating drug interactions, and practical steps for protecting vulnerable patients.
With expert insights and real-world scenarios, this conversation is a must-listen for GPs striving to stay ahead of the evolving challenges of COVID-19.
This interview is for healthcare professionals only.
This interview is produced by DrivetimeRadio with the support of The Baker Heart and Diabetes Institute in collaboration with Pfizer Australia Pty Limited. Sydney, Australia. PP-C1D-AUS-0522, 06/25. Please go to our website to access CPD options, supporting references, resources, and the product PI: www.drivetimeradio.com.au/programs/gp/
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
